Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Heba S. Zaky, Somaia A. Abdel-Sattar, Albatoul Allam & Hebatalla I. Ahmed. (2023) Further insights into the impact of rebamipide on gentamicin-induced nephrotoxicity in rats: modulation of SIRT1 and β-catenin/cyclin D1 pathways. Drug and Chemical Toxicology 46:5, pages 851-863.
Read now
Read now
Huiqin Gao, Lunan Li, Chenjing Zhang, Jiangfeng Tu, Xiaoge Geng, Jingya Wang, Xiaolu Zhou, Jiyong Jing & Wensheng Pan. (2020) Comparison of efficacy of pharmacological therapies for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and network meta-analysis. Expert Review of Gastroenterology & Hepatology 14:3, pages 207-220.
Read now
Read now
Osamu Handa, Shun Takayama, Rieko Mukai, Yosuke Suyama, Atsushi Majima, Akifumi Fukui, Tatsushi Omatsu & Yuji Naito. (2018) A review of the mechanism and prophylaxis of acetyl salicylic acid-induced injury of the small intestine. Free Radical Research 52:11-12, pages 1266-1270.
Read now
Read now
Articles from other publishers (79)
Saori Deguchi, Ayusa Iwakami, Mizuki Tujigiwa, Hiroko Otake, Yu Mano, Naoki Yamamoto, Yosuke Nakazawa, Manju Misra & Noriaki Nagai. (2023) Recovery from indomethacin-induced gastrointestinal bleeding by treatment with teprenone. Journal of Pharmaceutical Health Care and Sciences 9:1.
Crossref
Crossref
Emilio Mateev, Magdalena Kondeva-Burdina, Maya Georgieva & Alexander Zlatkov. (2023) Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study. Journal of Molecular Graphics and Modelling 122, pages 108471.
Crossref
Crossref
V. B. Grinevich, L. B. Lazebnik, Yu. A. Kravchuk, V. G. Radchenko, E. I. Tkachenko, A. M. Pershko, P. V. Seliverstov, C. P. Salikova, K. V. Zhdanov, K. V. Kozlov, V. V. Makienko, I. V. Potapova, E. S. Ivanyuk, D. V. Egorov, E. I. Sas, M. D. Korzheva, N. M. Kozlova, A. K. Ratnikova, V. A. Ratnikov, S. I. Sitkin, L. Z. Bolieva, C. V. Turkina, D. I. Abdulganieva, T. V. Ermolova, S. A. Kozhevnikova, L. V. Tarasova, R. G. Myazin, N. M. Khomeriki, T. L. Pilat, L. P. Kuzmina, R. A. Khanferyan, V. P. Novikova, A. V. Polunina & A. I. Khavkin. (2023) Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines. Experimental and Clinical Gastroenterology:12, pages 4-68.
Crossref
Crossref
D. N. Andreev, D. S. Bordin, K. А. Nikolskaya, A. R. Dzhafarova & V. V. Cherenkova. (2023) Current trends in <i>Helicobacter pylori</i> eradication therapy. Meditsinskiy sovet = Medical Council:8, pages 18-27.
Crossref
Crossref
Natalia V. Bakulina, Sergey V. Tikhonov, Sergey V. Okovityi, Elena A. Lutaenko, Alexandеr O. Bolshakov, Veronika A. Prikhodko & Anna S. Nekrasova. (2023) Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review. Terapevticheskii arkhiv 94:12, pages 1431-1437.
Crossref
Crossref
Won Moon, Sangwook Lim, Yeonsoon Jung, Yuk Moon Heo, Seun Ja Park, Moo In Park, Sung Eun Kim, Jae Hyun Kim & Kyoungwon Jung. (2022) The effects of rebamipide, sucralfate, and rifaximin against inflammation and apoptosis in radiation-induced murine intestinal injury. Kosin Medical Journal 37:4, pages 320-341.
Crossref
Crossref
Wei Shen, Xiaoyan Zhao, Zhen Han, Yinglei Miao, Hua Huang, Zhenyu Zhang, Lei Dong, Yuqiang Nie, Huimei Li & RunZhou Ni. (2022) Efficacy and safety of polaprezinc in the treatment of gastric ulcer: A multicenter, randomized, double-blind, double-dummy, positive-controlled clinical trial. Medical Engineering & Physics 110, pages 103860.
Crossref
Crossref
Vladimir I. Simanenkov, Igor V. Maev, Olga N. Tkacheva, Sergei A. Alekseenko, Dmitry Andreev, Natalia V. Bakulina, Igor G. Bakulin, Dmitry S. Bordin, Timur D. Vlasov, Natalya M. Vorobyeva, Vladimir B. Grinevich, Irina V. Gubonina, Michail Y. Drobizhev, Nikolay S. Efremov, Andrey E. Karateev, Yulia V. Kotovskaya, Iurii Kravchuk, Grigory G. Krivoborodov, Ekaterina V. Kulchavenya, Aleksander M. Lila, Marina V. Maevskaya, Anna S. Nekrasova, Elena A. Poluektova, Tatiana V. Popkova, Oleg A. Sablin, Olga I. Solovyeva, Alexander N. Suvorov, Galina N. Tarasova, Dmity I. Trukhan & Anastasia V. Fedotova. (2022) Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians. Terapevticheskii arkhiv 94:8, pages 940-956.
Crossref
Crossref
M. E. Statsenko, S. V. Turkina, I. A. Tyshchenko, N. N. Shilina & A. M. Streltsova. (2022) Evaluation of the effi cacy of rebamipide in functional dyspepsia and irritable bowel syndrome treatment. Experimental and Clinical Gastroenterology:9, pages 74-81.
Crossref
Crossref
A.A. Frolova, T.S. Shindina, L.V. Maslovsky, M.L. Maksimov, E.B. Aleksandrova & O.E. Kropova. (2022) Mechanism of action of gastroprotective agent rebamipide. Glavvrač (Chief Medical Officer):8, pages 23-25.
Crossref
Crossref
Yury P. Uspenskiy, Natalia V. Baryshnikova, Alexey A. Krasnov, Sergey V. Petlenko & Vera A. Apryatina. (2022) Topical issues of prevention of stomach cancer: A review. Consilium Medicum 24:5, pages 358-364.
Crossref
Crossref
Dmitry N. Andreev, Igor V. Maev, Dmitry S. Bordin, Svetlana V. Lyamina, Diana T. Dicheva, Aleksei K. Fomenko & Armine S. Bagdasarian. (2022) Effectiveness of Rebamipide as a part of the <i>Helicobacter pylori</i> eradication therapy in Russia: a meta-analysis of controlled trials. Consilium Medicum 24:5, pages 333-338.
Crossref
Crossref
A. A. Frolova, T. S. Shindina, L. V. Maslovskiy, M. L. Maksimov, E. B. Aleksandrova & O. E. Kropova. (2022) Use of rebamipide gastroprotector agent in clinical practice. Glavvrač (Chief Medical Officer):7, pages 52-58.
Crossref
Crossref
Sung Eun Kim. (2022) Mucoprotectants. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 22:2, pages 108-118.
Crossref
Crossref
Joon Seop Lee, Seong Woo Jeon, Hyun Seok Lee, Yong Hwan Kwon, Su Youn Nam, Han Ik Bae & An Na Seo. (2021) Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study. Digestive Diseases and Sciences 67:6, pages 2395-2402.
Crossref
Crossref
A. A. Frolova, T. S. Shindina, L. V. Maslovsky, M. L. Maksimov, E. B. Aleksandrova & O. E. Kropova. (2022) Gastroprotectant Rebamipide: review of action mechanisms and clinical applications. Glavvrač (Chief Medical Officer):4, pages 11-31.
Crossref
Crossref
Jimin Jeon & Jinkwon Kim. (2022) Risk of Post-Myocardial Infarction Pneumonia with Proton Pump Inhibitors, H2 Receptor Antagonists and Mucoprotective Agents: A Retrospective Nationwide Cohort Study. Journal of Personalized Medicine 12:1, pages 78.
Crossref
Crossref
I. N. Tikhonov, V. T. Ivashkin, M. S. Zharkova, M. V. Maevskaya, S. N. Koloteeva, A. S. Sarsenbaeva, L I. Tkachenko, O. V. Aronova, E. K. Tsvetaeva & N I. Trofimovskaya. (2022) Results of the non-interventional observational program: Influence of Novel COroNavirus on the condition of patients with liver and gastrointestinal Tract diseases and the effect of Ursodeoxycholic acid drugs and Rebamipide on the course of COVID-19 infection (CONTUR). Meditsinskiy sovet = Medical Council:21-1, pages 106-119.
Crossref
Crossref
M. D. Ardatskaya, L. V. Maslovskii & I. V. Zverkov. (2022) Is it necessary to correct the intestinal microbiota disorders in chronic pancreatitis?. Experimental and Clinical Gastroenterology:11, pages 52-59.
Crossref
Crossref
V. T. Ivashkin, I. V. Maev, T. L. Lapina, E. D. Fedorov, A. A. Sheptulin, A. S. Trukhmanov, A. V. Kononov, R. A. Abdulkhakov, O. P. Alexeeva, S. A. Alekseenko, D. N. Andreev, E. K. BaranskayaN. N. Dekhnich, I. L. Klyaritskaya, R. S. Kozlov, E. A. KoganM. P. Korolev, N. V. Korochanskaya, S. A. Kurilovich, M. A. Livsan, M. F. Osipenko, P. V. PavlovS. S. Pirogov, A. S. Sarsenbaeva, V. I. Simanenkov, A. S. Tertychny, A. V. Tkachev, Yu. P. Uspensky, I. B. Khlynov & V. V. Tsukanov. (2021) Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 31:4, pages 70-99.
Crossref
Crossref
A. E. Babich, E. V. Luchinina, O. G. Kompaniets & N. A. Zubareva. (2021) Rebamipid in real clinical practice: quality of life and safety of use. Medical alphabet:35, pages 7-11.
Crossref
Crossref
Akshita Jindal, Rishav Singh, Sakshi Tomar, Janhvi Dureja, Maninder Karan & Renu Chadha. (2021) Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies. Pharmaceutical Research 38:12, pages 2129-2145.
Crossref
Crossref
Gwang Ha Kim, Hang Lak Lee, Moon Kyung Joo, Hong Jun Park, Sung Woo Jung, Ok-Jae Lee, Hyungkil Kim, Hoon Jai Chun, Soo Teik Lee, Ji Won Kim, Han Ho Jeon, Il-Kwun Chung, Hyun-Soo Kim, Dong Ho Lee, Kyoung-Oh Kim, Yun Jeong Lim, Seun-Ja Park, Soo-Jeong Cho, Byung-Wook Kim, Kwang Hyun Ko, Seong Woo Jeon, Jae Gyu Kim, In-Kyung Sung, Tae Nyeun Kim, Jae Kyu Sung & Jong-Jae Park. (2021) Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study. Gut and Liver 15:6, pages 841-850.
Crossref
Crossref
Susanta Mandal, Samuzal Bhuyan, Saibal Jana, Jagir Hossain, Karan Chhetri & Biswajit Gopal Roy. (2021)
Efficient visible light mediated synthesis of quinolin-2(1
H
)-ones from quinoline
N
-oxides
. Green Chemistry 23:14, pages 5049-5055.
Crossref
Crossref
V. B. Grinevich, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, S. P. Salikova, I. V. Gubonina, E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik, E. V. Golovanova, E. A. Belousova, P. A. Makarchuk, E. Yu. Eremina, A. S. Sarsenbaeva, D. I. Abdulganieva, L. V. Tarasova, O. A. Gromova, V. A. Ratnikov, K. V. Kozlov & A. K. Ratnikova. (2021) Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition). Experimental and Clinical Gastroenterology:3, pages 5-82.
Crossref
Crossref
D. N. Andreev, A. V. Zaborovsky & E. G. Lobanova. (2021) Gastroesophageal reflux disease: new approaches to optimizing pharmacotherapy. Meditsinskiy sovet = Medical Council:5, pages 30-37.
Crossref
Crossref
Da Hyun Jung, Jun Chul Park, Yong Chan Lee, Sang Kil Lee, Sung Kwan Shin, Hyunsoo Chung, Jae Jun Park, Jie-Hyun Kim, Young Hoon Youn & Hyojin Park. (2021) Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers. Journal of Clinical Gastroenterology 55:3, pages 233-238.
Crossref
Crossref
Irina Yurievna Kolesnikova, Irina Vyacheslavovna Ivakhnenko, Anzhelika Viktorovna Ponomareva & Sergey Ivanovich Krayushkin. (2020) Modern aspects of eradication therapy. Spravočnik vrača obŝej praktiki (Journal of Family Medicine):12, pages 36-45.
Crossref
Crossref
D. N. Andreev & I. V. Maev. (2020) Rebamipide: evidence base for use in gastroenterology. Terapevticheskii arkhiv 92:12, pages 97-104.
Crossref
Crossref
V. B. Grinevich, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, S. P. Salikova, I. V. Gubonina, E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik & E. V. Golovanova. (2020) Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by the Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology:7, pages 4-51.
Crossref
Crossref
Lihong Zhang & Jiantao Liu. (2020) Solubility Determination and Correlation of 4-(Bromomethyl)-2(1H)-quinolinone in Different Pure Solvents Over the Temperature Range from 273.15 to 313.15 K. Journal of Chemical & Engineering Data 65:9, pages 4468-4474.
Crossref
Crossref
Milica Markovic, Moran Zur, Arik Dahan & Sandra Cvijić. (2020) Biopharmaceutical characterization of rebamipide: The role of mucus binding in regional-dependent intestinal permeability. European Journal of Pharmaceutical Sciences 152, pages 105440.
Crossref
Crossref
V. B. Grinevich, Yu. A. Kravchuk, E. I. Tkachenko, A. M. Pershko, V. I. Ped, I. E. Sas, I. V. Gubonina, L. B. Lazebnik & O. V. Stefanyuk. (2020) Features of management of patients with gastroenterological pathology in the conditions of the COVID-19 pandemic. Experimental and Clinical Gastroenterology 174:4, pages 3-18.
Crossref
Crossref
Kai He, Alistair G. Borthwick, Yingchao Lin, Yuening Li, Jie Fu, Yongjie Wong & Wen Liu. (2020) Sale-based estimation of pharmaceutical concentrations and associated environmental risk in the Japanese wastewater system. Environment International 139, pages 105690.
Crossref
Crossref
D. N. Andreev & D. T. Dicheva. (2020) A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases. Meditsinskiy sovet = Medical Council:5, pages 87-95.
Crossref
Crossref
I. A. Viktorova, D. I. Trukhan & D. S. Ivanova. (2020) Modern opportunities for treatment and prevention of NSAID-induced enteropathies. Meditsinskiy sovet = Medical Council:5, pages 30-40.
Crossref
Crossref
N. Yu. Borovkova, M. V. Buyanova, V. V. Terekhova, T. E. Bakka, M. P. Nistratova & T. V. Vlasova. (2020) Aspirin-induced gastrointestinal lesions in patients with chronic coronary artery disease: special aspects and therapeutic options. Cardiovascular Therapy and Prevention 19:2, pages 2463.
Crossref
Crossref
M. Yu. Zvyaglova, O. V. Knyazev & A. I. Parfenov. (2020) Pharmacological and clinical feature of rebamipide: new therapeutic targets. Terapevticheskii arkhiv 92:2, pages 104-111.
Crossref
Crossref
Menghao Sun, Zheng Deng, Fei Shi, Zheng Zhou, Chenyi Jiang, Zhilu Xu, Xiaoming Cui, Wentong Li, Yifeng Jing, Bangmin Han, Weifen Zhang & Shujie Xia. (2020)
Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation
via
the NF-κB signaling pathway
. Biomaterials Science 8:3, pages 912-925.
Crossref
Crossref
Daorui Hou, Maoyi Yang, Zhipeng Hu & Liangjun Yang. (2020) Effects of rebamipide for chronic atrophic gastritis. Medicine 99:25, pages e20620.
Crossref
Crossref
A. E. Karateev, E. V. Moroz & E. V. Kryukov. (2019) Small intestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. Almanac of Clinical Medicine 47:6, pages 559-567.
Crossref
Crossref
Noriaki Nagai, Ryusuke Sakamoto, Seiji Yamamoto, Saori Deguchi, Hiroko Otake & Tadatoshi Tanino. (2019) Solid Nanocrystals of Rebamipide Promote Recovery from Indomethacin-Induced Gastrointestinal Bleeding. International Journal of Molecular Sciences 20:20, pages 4990.
Crossref
Crossref
Dmitrii N. Andreev, Igor V. Maev & Diana T. Dicheva. (2019) Efficiency of the Inclusion of Rebamipide in the Eradication Therapy for Helicobacter pylori Infection: Meta-Analysis of Randomized Controlled Studies. Journal of Clinical Medicine 8:9, pages 1498.
Crossref
Crossref
Rapat Pittayanon, Panida Piyachaturawat, Rungsun Rerknimitr, Piyapan Prueksapanich, Supakarn Chaitongrat, Vorarit Lertsuwunseri, Suphot Srimahachota & Varocha Mahachai. (2019) Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double‐blind placebo‐controlled trial. Journal of Gastroenterology and Hepatology 34:9, pages 1517-1522.
Crossref
Crossref
D. T. Dicheva, Yu. S. Subbotina, L. G. Bektemirova & D. N. Andreev. (2019) Functional dyspepsia: from pathogenesis to therapeutic aspects. Medical Council:3, pages 18-25.
Crossref
Crossref
Ryoma Tanaka, Yusuke Hattori, Yukun Horie, Hitoshi Kamada, Takuya Nagato & Makoto Otsuka. (2019) Characterization of Amorphous Solid Dispersion of Pharmaceutical Compound with pH-Dependent Solubility Prepared by Continuous-Spray Granulator. Pharmaceutics 11:4, pages 159.
Crossref
Crossref
Rapat Pittayanon, Myriam Martel & Alan Barkun. (2018) Role of mucoprotective agents in endoscopic submucosal dissection‐derived ulcers: A systematic review. Journal of Gastroenterology and Hepatology 33:12, pages 1948-1955.
Crossref
Crossref
Hitoshi Watanabe. (2018) Medical Treatment for Dry Eye in Japan. Investigative Opthalmology & Visual Science 59:14, pages DES116.
Crossref
Crossref
D N Andreev, I V Maev, D T Dicheva, A A Samsonov & E V Partzvania-Vinogradova. (2018) Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study. Terapevticheskii arkhiv 90:8, pages 27-32.
Crossref
Crossref
Mohammed Ziaei, Carol Greene & Colin R. Green. (2018) Wound healing in the eye: Therapeutic prospects. Advanced Drug Delivery Reviews 126, pages 162-176.
Crossref
Crossref
Yuriko Yasuda-Onozawa, Osamu Handa, Yuji Naito, Chihiro Ushiroda, Yosuke Suyama, Yuki Toyokawa, Takaaki Murakami, Tomoyo Yasuda, Tomohiro Ueda, Atsushi Majima, Yuma Hotta, Toshifumi Doi, Makoto Tanaka, Yusuke Horii, Yasuki Higashimura, Katsura Mizushima, Mayuko Morita, Yukiko Uehara, Hideki Horie, Akifumi Fukui, Osamu Dohi, Tetsuya Okayama, Naohisa Yoshida, Kazuhiro Kamada, Kazuhiro Katada, Kazuhiko Uchiyama, Takeshi Ishikawa, Tomohisa Takagi, Hideyuki Konishi & Yoshito Itoh. (2017) Rebamipide upregulates mucin secretion of intestinal goblet cells via Akt phosphorylation. Molecular Medicine Reports 16:6, pages 8216-8222.
Crossref
Crossref
Ichiro Kawaguchi, Akira Kobayashi, Tomomi Higashide, Yasuhiro Takeji, Kazushi Sakurai, Chiaki Kawaguchi & Kazuhisa Sugiyama. (2017) Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits. PLOS ONE 12:10, pages e0186714.
Crossref
Crossref
Takako Nakashima, Naoya Uematsu & Kazushi Sakurai. (2017) Intra-oral administration of rebamipide liquid prevents tongue injuries induced by X-ray irradiation in rats. Supportive Care in Cancer 25:7, pages 2205-2213.
Crossref
Crossref
D N Andreev, D T Dicheva & I V Maev. (2017) Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice. Terapevticheskii arkhiv 89:2, pages 84-90.
Crossref
Crossref
Sunyoung Lee, Seongkeun Jeong, Wooseong Kim, Dohoon Kim, Yejin Yang, Jeong-Hyun Yoon, Byung Joo Kim, Do Sik Min & Yunjin Jung. (2017) Rebamipide induces the gastric mucosal protective factor, cyclooxygenase-2, via activation of 5′-AMP-activated protein kinase. Biochemical and Biophysical Research Communications 483:1, pages 449-455.
Crossref
Crossref
O M Drapkina & O N Korneeva. (2016) Small bowel injuries due to nonsteroidal anti-inflammatory drugs and antiplatelet therapy. Approaches to prevention and treatment. Terapevticheskii arkhiv 88:12, pages 133-139.
Crossref
Crossref
Takashi Izawa, Hiroki Mori, Tekehiro Shinohara, Akiko Mino-Oka, Islamy Rahma Hutami, Akihiko Iwasa & Eiji Tanaka. (2016) Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis. PLOS ONE 11:4, pages e0154107.
Crossref
Crossref
Yuki Nanke, Tsuyoshi Kobashigawa, Toru Yago, Manabu Kawamoto, Hisashi Yamanaka & Shigeru Kotake. (2016) Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts. BioMed Research International 2016, pages 1-7.
Crossref
Crossref
Masafumi Shibamori, Masayuki Sato, Naoya Uematsu, Takako Nakashima, Asuka Sato, Yoshiya Yamamura, Hiroyuki Sasabe, Ken Umehara & Kazushi Sakurai. (2015) Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice. Journal of Pharmacological Sciences 129:1, pages 18-25.
Crossref
Crossref
Toshio Watanabe, Toshihisa Takeuchi, Osamu Handa, Yasuhisa Sakata, Tetsuya Tanigawa, Masatsugu Shiba, Yuji Naito, Kazuhide Higuchi, Kazuma Fujimoto, Toshikazu Yoshikawa & Tetsuo Arakawa. (2015) A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Rebamipide Treatment for Low-Dose Aspirin-Induced Moderate-to-Severe Small Intestinal Damage. PLOS ONE 10:4, pages e0122330.
Crossref
Crossref
K. Iijima, T. Koike, N. Ara, K. Nakagawa, Y. Kondo, K. Uno, W. Hatta, N. Asano, A. Imatani & T. Shimosegawa. (2014) Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects. Journal of Gastroenterology 50:3, pages 305-312.
Crossref
Crossref
Satoshi Kurata, Takako NakashimaTakako Osaki, Naoya UematsuMasafumi ShibamoriKazushi SakuraiShigeru Kamiya. (2015) Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model. Journal of Clinical Biochemistry and Nutrition 56:1, pages 20-27.
Crossref
Crossref
Toshihiro Nishizawa, Hidekazu Suzuki, Takanori Kanai & Naohisa Yahagi. (2015) Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis. Journal of Clinical Biochemistry and Nutrition 56:2, pages 85-90.
Crossref
Crossref
Tsutomu Igarashi, Miho Fujita, Yumi Yamada, Maika Kobayashi, Chiaki Fujimoto, Hisatomo Takahashi, Toru Igarashi, Yuichiro Nakano, Hisaharu Suzuki & Hiroshi Takahashi. (2015) Improvements in Signs and Symptoms of Dry Eye after Instillation of 2% Rebamipide. Journal of Nippon Medical School 82:5, pages 229-236.
Crossref
Crossref
Naoto Tokuda, Yasushi Kitaoka, Akiko Matsuzawa, Junsuke Miyamoto, Shinsuke Sakae, Yasunari Munemasa & Hitoshi Takagi. (2015) The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients. Journal of Ophthalmology 2015, pages 1-5.
Crossref
Crossref
Ken Fukuda, Waka Ishida, Hiroshi Tanaka, Yosuke Harada & Atsuki Fukushima. (2014) Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts. British Journal of Ophthalmology 98:12, pages 1751-1755.
Crossref
Crossref
Toshihiro Nishizawa, Yuko Nishizawa, Naohisa Yahagi, Takanori Kanai, Masahiko Takahashi & Hidekazu Suzuki. (2014)
Effect of supplementation with rebamipide for
Helicobacter pylori
eradication therapy: A systematic review and meta-analysis
. Journal of Gastroenterology and Hepatology 29, pages 20-24.
Crossref
Crossref
Napapan Kangwan, Jong Min Park & Ki Baik Hahm. (2014) Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology. Current Opinion in Pharmacology 19, pages 17-23.
Crossref
Crossref
Rieko Arakaki, Hiroshi Eguchi, Akiko Yamada, Yasusei Kudo, Akihiko Iwasa, Tserennadmid Enkhmaa, Fumika Hotta, Sayaka Mitamura-Aizawa, Yoshinori Mitamura, Yoshio Hayashi & Naozumi Ishimaru. (2014) Anti-Inflammatory Effects of Rebamipide Eyedrop Administration on Ocular Lesions in a Murine Model of Primary Sjögren's Syndrome. PLoS ONE 9:5, pages e98390.
Crossref
Crossref
Dustin L. Cooper, Robert C. WoodIIIIII, Jarrett E. Wyatt & Sam Harirforoosh. (2014) Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats. European Journal of Pharmaceutical Sciences 53, pages 28-34.
Crossref
Crossref
Hiroshi Satoh, Kikuko Amagase & Koji Takeuchi. (2014) Mucosal Protective Agents Prevent Exacerbation of NSAID-Induced Small Intestinal Lesions Caused by Antisecretory Drugs in Rats. Journal of Pharmacology and Experimental Therapeutics 348:2, pages 227-235.
Crossref
Crossref
Konstantin V. Kudryavtsev, Anna O. Markevich, Oleksandr V. Virchenko, Tetyana M. Falalyeyeva, Tetyana V. Beregova, Lyudmyla I. Ostapchenko, Dmitry V. Zabolotnev & Nikolay S. Zefirov. (2014) Pharmacological Correction of Stress-Induced Gastric Ulceration by Novel Small-Molecule Agents with Antioxidant Profile. The Scientific World Journal 2014, pages 1-6.
Crossref
Crossref
Shizuka Koh, Yasushi Inoue, Toshiki Sugmimoto, Naoyuki Maeda & Kohji Nishida. (2013) Effect of Rebamipide Ophthalmic Suspension on Optical Quality in the Short Break-up Time Type of Dry Eye. Cornea 32:9, pages 1219-1223.
Crossref
Crossref
Hiroshi Tanaka, Ken Fukuda, Waka Ishida, Yosuke Harada, Tamaki Sumi & Atsuki Fukushima. (2013) Rebamipide increases barrier function and attenuates TNFα-induced barrier disruption and cytokine expression in human corneal epithelial cells. British Journal of Ophthalmology 97:7, pages 912-916.
Crossref
Crossref
Rhodri Stacey & John T. Green. (2013) Nonendoscopic therapies for the management of radiation-induced rectal bleeding. Current Opinion in Supportive & Palliative Care 7:2, pages 175-182.
Crossref
Crossref
Shigeru Kinoshita, Kazuhide Oshiden, Saki Awamura, Hiroyuki Suzuki, Norihiro Nakamichi & Norihiko Yokoi. (2013) A Randomized, Multicenter Phase 3 Study Comparing 2% Rebamipide (OPC-12759) with 0.1% Sodium Hyaluronate in the Treatment of Dry Eye. Ophthalmology 120:6, pages 1158-1165.
Crossref
Crossref
Shinya Yamada, Yuji Naito, Tomohisa Takagi, Katsura Mizushima, Ryusuke Horie, Kohei Fukumoto, Ken Inoue, Akihito Harusato, Kazuhiko Uchiyama, Osamu Handa, Nobuaki Yagi, Hiroshi Ichikawa & Toshikazu Yoshikawa. (2012) Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity. Journal of Gastroenterology and Hepatology 27:12, pages 1816-1824.
Crossref
Crossref
Shigeru Kinoshita, Saki Awamura, Kazuhide Oshiden, Norihiro Nakamichi, Hiroyuki Suzuki & Norihiko Yokoi. (2012) Rebamipide (OPC-12759) in the Treatment of Dry Eye: A Randomized, Double-Masked, Multicenter, Placebo-Controlled Phase II Study. Ophthalmology 119:12, pages 2471-2478.
Crossref
Crossref
Yuji Naito. (2011) Editorial. Journal of Clinical Biochemistry and Nutrition 48:2, pages 101-102.
Crossref
Crossref